Jun 2021 $4 M No. 7 $2 to $10 million 36
Soft Tissue Regeneration, Inc.: Raise no. 7, Jun 2021 × Investors in this round 36 investors had bought by the notice of Jun 25, 2021: 36 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, other: Convertible Promissory Notes Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jeffery A. Baird · Executive Officer Kevin A Rocco · Executive Officer, Director Daniel A Wagner · Director Nicholas A Pachuda · Director Paul A Hermes · Director Richard A Emmitt · Director Sacha A Levy · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No amounts other than ordinary course employment compensation is being paid to officers and directors.”Signed by Kevin A. Rocco, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2021. Read the notice at the SEC .
debt, options SEC Jul 2019 $4 M No. 6 $2 to $10 million 33
Soft Tissue Regeneration, Inc.: Raise no. 6, Jul 2019 × Investors in this round 33 investors had bought by the notice of Sep 16, 2020: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $166,690 (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kevin A. Rocco · Executive Officer, Director Daniel A. Wagner · Director Levy A. Sacha · Director Paul A. Hermes · Director Richard A. Emmitt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kevin A. Rocco, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 16, 2020. Read the notice at the SEC .
equity SEC Mar 2018 $1 M No. 5 Under $2 million 15
Soft Tissue Regeneration, Inc.: Raise no. 5, Mar 2018 × Investors in this round 15 investors had bought by the notice of Mar 14, 2018: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kevin A Rocco · Executive Officer, Director Daniel A Wagner · Director Konstantine A Drakonakis · Director Paul A Hermes · Director Richard A Emmitt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No payments other than ordinary course employment compensation is being paid to executive officers.”Signed by Kevin A. Rocco, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 14, 2018. Read the notice at the SEC .
equity SEC Nov 2016 $1 M No. 4 Under $2 million 6
Soft Tissue Regeneration, Inc.: Raise no. 4, Nov 2016 × Investors in this round 6 investors had bought by the notice of Dec 5, 2016: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $2 M offered; $1 M still to sell
Smallest investment taken $25,000
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $150,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Kevin Rocco · Executive Officer, Director Daniel Wagner · Director Konstantine Drakonakis · Director Richard Emmitt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Kevin Rocco, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 5, 2016. Read the notice at the SEC .
equity, options SEC Nov 2013 $8 M No. 3 $2 to $10 million 19
Soft Tissue Regeneration, Inc.: Raise no. 3, Nov 2013 × Investors in this round 19 investors had bought by the notice of Nov 4, 2015: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $9 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $750,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Joseph W Reilly · Executive Officer, Director, Promoter Charles B Hart · Director Daniel B Wagner · Director Konstantine B Drakonakis · Director Michael B Aronson · Director Richard B Emmitt · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph W. Reilly, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 4, 2015. Read the notice at the SEC .
equity, options SEC Sep 2011 $4 M No. 2 $2 to $10 million 15
Soft Tissue Regeneration, Inc.: Raise no. 2, Sep 2011 × Investors in this round 15 investors had bought by the notice of Mar 11, 2013: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $654,750 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Joseph W Reilly · Executive Officer, Director, Promoter Cato T Laurencin · Director, Promoter Michael B Aronson · Director Robert S Langer · Director Russell E Tweeddale · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph W. Reilly, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 11, 2013. Read the notice at the SEC .
debt, options SEC Jul 2009 $3 M No. 1 $2 to $10 million 13
Soft Tissue Regeneration, Inc.: Raise no. 1, Jul 2009 × Investors in this round 13 investors had bought by the notice of Jul 7, 2010: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered; $0 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last more than a year
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people $800,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Joseph W Reilly · Executive Officer, Director, Promoter Cato T Laurencin · Director, Promoter Michael B Aronson · Director Robert S Langer · Director Russell E Tweeddale · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Joseph W. Reilly, President and chief executive officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 7, 2010. Read the notice at the SEC .
equity SEC